Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 121

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 8
Chunk 121
---
Item 8. Financial Information

A. Consolidated Statements
and Other Financial Information

Our audited consolidated financial
statements for the fiscal years ending June 30, 2025, 2024 and 2023 are included in Item 18 of this Annual Report on Form 20-F,
which is found immediately following the text of this Annual Report on Form 20-F. The audit reports of Grant Thornton Audit Pty Ltd as
of June 30, 2025, 2024 and 2023 are included therein immediately preceding the financial statements.

Legal Proceedings

We are not involved in any
legal or arbitration proceedings that could have a material adverse impact on our financial position or profitability. We are not currently
involved in any governmental proceedings and, to our knowledge, none are contemplated.

Dividend Distribution Policy

We have never paid cash dividends
to our shareholders. We intend to retain future earnings for use in our business and do not anticipate paying cash dividends on our ordinary
shares in the foreseeable future. Any future dividend policy will be determined by the Board of Directors and will be based upon various
factors, including our results of operations, financial condition, current and anticipated cash needs, future prospects, contractual restrictions
and other factors as the Board of Directors may deem relevant. There is no assurance that dividends will ever be paid. See “ Special
Note Regarding Forward Looking Statements”.

B. Significant Changes

No significant changes occurred since the date
of the annual financial statements.

Item 9. The Offer and
Listing

A. Offer and Listing Details

Our ADSs trade on the Nasdaq
Capital Market under the symbol “ RADX” and our ordinary shares trade on the ASX under the symbol “ RAD”.

B. Plan of Distribution

Not applicable.

C. Markets

Our ordinary shares are listed and traded on the
ASX, under the symbol “ RAD”.

Our ADSs, each representing
300 of our ordinary shares, are listed on the Nasdaq Capital Market under the symbol “ RADX”.

D. Selling Shareholders

Not applicable.

E. Dilution

Not applicable.

F. Expenses of the Issue

Not applicable.

Item 10. Additional
Information

A. Share Capital

Not applicable.

B. Memorandum and Articles of Association

General

Our constituent document is
a Constitution. The Constitution is subject to the terms of the Listing Rules of ASX Limited and the Corporations Act 2001. The Constitution
may be amended or repealed and replaced by special resolution of